What is the use of Buscopan (hyoscine butylbromide) in treating smooth muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Buscopan (Hyoscine Butylbromide) Use in Treating Smooth Muscle Spasms

Buscopan (hyoscine butylbromide) is an antimuscarinic antispasmodic medication primarily used to relieve abdominal pain associated with gastrointestinal smooth muscle spasms, with demonstrated efficacy in reducing cramping through its anticholinergic action on muscarinic receptors in the GI tract.

Mechanism of Action

Hyoscine butylbromide works through:

  • Anticholinergic effects with high affinity for muscarinic receptors on gastrointestinal smooth muscle cells 1
  • Blockade of muscarinic receptors in the GI tract, resulting in smooth muscle relaxation and spasmolytic effects
  • Binding to nicotinic receptors, producing a ganglion-blocking effect 1
  • Concentration-dependent inhibition of smooth muscle activity, particularly effective against spasticity induced by cholinergic stimulation 2

Clinical Applications

Primary Indications

  • Gastrointestinal smooth muscle spasms
    • Irritable bowel syndrome (IBS) with abdominal pain and cramping 3
    • Acute abdominal spasms and cramps 1
    • Biliary and renal colic (parenteral administration) 4

Secondary Uses

  • Diagnostic and therapeutic procedures

    • Radiological imaging to distend the GI tract and reduce motion artifacts 5, 4
    • Endoscopic procedures to facilitate examination 4
    • Computed tomographic colonography to improve image quality 4
  • Other applications

    • Labor: Shortening of labor duration through cervical relaxation 4
    • Palliative care: Relief of pain and reduction of GI secretions in terminal cancer patients with bowel obstruction 4

Dosage and Administration

Oral Administration

  • Standard dose: 10-20 mg, 3-4 times daily 3
  • For acute spasms: 20 mg as needed

Parenteral Administration

  • Intravenous: 20-40 mg for acute spasms 4
  • Onset of action: Within 10 minutes when given intravenously 4
  • Duration of effect: Approximately 30 minutes to 2 hours

Efficacy

  • Pain reduction of 42-78% observed in biliary colic within 30 minutes after a single IV injection of 20 mg 4
  • Approximately 90% of patients with renal colic showed good to moderate analgesic responses after 30 minutes of IV administration 4
  • Meta-analysis of antispasmodics in IBS showed significant improvement in global symptoms and abdominal pain compared to placebo 3

Advantages Over Other Antispasmodics

  • As a quaternary ammonium compound, it does not cross the blood-brain barrier, minimizing central nervous system effects 1, 4
  • Low systemic bioavailability (<1%) after oral administration, with high tissue affinity for intestinal muscarinic receptors 1
  • Remains available at the site of action in the intestine due to its high tissue affinity 1
  • Different inhibitory effectiveness on various parts of the GI tract, with increasing sensitivity from the esophagus to the ileum 2

Safety Profile and Side Effects

Common Side Effects

  • Typical anticholinergic effects:
    • Dry mouth
    • Blurred vision (temporary impairment of visual accommodation) 5
    • Constipation
    • Urinary retention

Safety Considerations

  • Generally well tolerated due to minimal systemic absorption 1
  • Minor abnormalities of near vision may occur in patients under 50 years, typically resolving within 12-21 minutes 5
  • No significant impairment of distance vision or driving ability reported 5
  • Self-limiting adverse events typical for anticholinergic drugs 4

Precautions and Contraindications

  • Use with caution in:
    • Glaucoma
    • Prostatic hypertrophy
    • Cardiac conditions
    • Myasthenia gravis
    • Elderly patients (increased sensitivity to anticholinergic effects)

Clinical Pearls

  • Buscopan is more effective for spasms induced by cholinergic stimulation than those caused by high potassium concentrations 2
  • The inhibitory effect shows a gradient of increasing sensitivity from the esophagus to the ileum 2
  • Small doses (10-20 mg IV) are adequate for diagnostic procedures with minimal side effects 6
  • For IBS, antispasmodics including hyoscine butylbromide are among the most frequently used over-the-counter treatments 3

Buscopan remains a valuable treatment option for patients with abdominal pain or discomfort associated with smooth muscle spasms, particularly in the gastrointestinal tract, with a favorable efficacy and safety profile.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.